Current Cancer Drug Targets

译名:当代癌症药物靶点

CURRENT CANCER DRUG TARGETS

SCIEJCR Q3中科院4区

1-3

2026

影响因子区间

平台估算

投稿周期

59%

2025

中国作者发文占比

1800 EUR

费用说明

收费

期刊简介:Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

【译文】当前癌症药物靶点旨在涵盖所有关于当代分子药物靶点在癌症中的最新和杰出发展,例如疾病特异性蛋白质、受体、酶和基因。当前癌症药物靶点发表原创研究文章、信件、综述/迷你综述、药物临床试验研究和由该领域领导者撰写的主题特刊,涵盖涉及癌症药物靶点的当前一系列主题。随着新型人药物靶点的发现、鉴定、特征描述和验证在抗癌药物发现中不断增长;这本期刊已成为所有参与药物发现和开发的制药科学家必读之物。

出版社
Bentham Science Publishers
语言
English
学科
医学
ISSN
1568-0096
eISSN
1873-5576
出版频率
11期/年
创刊年份
2001
投稿网址
http://bsp-cms.eurekaselect.com/index.php/CCDT
最近更新
2026-04-02 18:16:40
Current Cancer Drug Targets

指标当前值近三年趋势
JCR分区Q3
暂无
中科院分区4区
暂无
影响因子区间1-3
暂无